±èÀº¿µ ¸íÀÇ

ȯÀÚ ¾ÈÀüÀ» ¿ì¼±À¸·Î »ý°¢ÇÏ´Â ³úÁ¾¾ç ¼ö¼ú ±ÇÀ§ÀÚ

±èÀº¿µ ¸íÀÇ

  • ¼Ò ¼Ó
    °¡Å縯°üµ¿´ëÇб³ ±¹Á¦¼º¸ðº´¿ø ½Å°æ¿Ü°ú
  • Àü¹®ºÐ¾ß
    ³úÁ¾¾ç, ¾È¸é°æ·ÃÁõ, »ïÂ÷½Å°æÅë, ¾È¸é°æ·ÃÁõ, ¼Ò¾Æ½Å°æ¿Ü°ú, ¼öµÎÁõ, µÎ°³Àú¼ö¼ú

ÁÖ¿ä Áø·áºÐ¾ß´Â ³úÁ¾¾ç, µÎ°³Àú¼ö¼ú, »ïÂ÷½Å°æÅë, ¾È¸é°æ·ÃÁõ, ¼öµÎÁõ, ¼Ò¾Æ½Å°æ¿Ü°ú µîÀÌ´Ù. µÎ°³Àú¿Ü°úÇÐȸ ¹× ´ëÇѳú½Å°æ±â´ÉÀå¾Ö ¿¬±¸È¸ ȸÀåÀ» ¿ªÀÓÇÏ¸ç ±¹³» ½Å°æ¿Ü°ú ºÐ¾ß ÇÐȸ¸¦ À̲ö ¹Ù ÀÖ´Ù. ÇöÀç´Â °¡Å縯°üµ¿´ëÇб³ ±¹Á¦¼º¸ðº´¿ø ½Å°æ¿Ü°ú¿¡ ÀçÁ÷ ÁßÀÌ´Ù. ³úÁ¾¾ç ¼ö¼ú 1500·Ê, ¾È¸é°æ·ÃÁõ, »ïÂ÷½Å°æÅë ¹Ì¼¼Ç÷°ü°¨¾Ð¼ú 750·Ê µî dzºÎÇÔ °æÇèÀ» ¹ÙÅÁÀ¸·Î ȯÀÚ Áß½ÉÀÇ Áø·á¸¦ Ãß±¸ÇÑ´Ù. ÀÌ ¿Ü¿¡µµ ½Å°æ¿Ü°úÇÐ ¹× µÎ°³Àú¿Ü°úÇÐ ±³°ú¼­¸¦ ÁýÇÊÇßÀ¸¸ç ¸¹Àº ¿¬±¸³í¹®À» ¹ßÇ¥Çß´Ù.

¸íÀÇÇÁ·ÎÇÊ ¸íÀÇ ÇÁ·ÎÇÊ

ÇзÂ

Educational Background
  • ÇѾç´ëÇб³ ÀÇ´ë Çлç
  • ÇѾç´ëÇб³ ÀÇ´ë ¼®»ç
  • ÇѾç´ëÇб³ ÀÇ´ë ¹Ú»ç

ÁÖ¿ä°æ·Â

Work Experience
  • úÞ) °¡Å縯°üµ¿´ëÇб³ ±¹Á¦¼º¸ðº´¿ø ½Å°æ¿Ü°ú ±³¼ö
  • ÀÎÇϴ뺴¿ø ½Å°æ¿Ü°ú ±³¼ö ¿ªÀÓ
  • ¹Ì±¹ ½Å½Ã³»Æ¼´ëÇÐ Research Fellow (µÎ°³Àú¼ö¼ú ¹× ³úÁ¾¾ç) ¿ªÀÓ
  • ¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø ½Å°æ¿Ü°ú ÀüÀÓÀÇ ¿ªÀÓ

ÇÐȸȰµ¿

Academic activities
  • 2022 ~ 2023´ëÇѳú½Å°æ±â´ÉÀå¾Ö¿¬±¸È¸ ȸÀå
  • 2011 ~ 2012´ëÇѵΰ³Àú¿Ü°úÇÐȸ ȸÀå
  • 1997 ~ ÇöÀç´ëÇѳúÁ¾¾ç¿Ü°úÇÐȸ ¿î¿µÀ§¿ø
µÎ°³ÀúÇÐ
´ëÇ¥¼­Àû

µÎ°³ÀúÇÐ

  • ÀúÀÚ(±Û)µÎ°³Àú¿Ü°úÇÐȸ
  • ÃâÆÇ»ç±ºÀÚÃâÆÇ»ç
  • ¹ßÇàÀÏ2023³â 11¿ù 22ÀÏ
Àú¼­ ¾ÆÀÌÄÜ

ÁýÇÊÀú¼­

ÃÑ 4°Ç
Á¦ ¸ñ µÎ°³Àú¿Ü°úÇÐ
ÃâÆÇ»ç ±ºÀÚÃâÆÇ»ç ¹ßÇàÀÏ 2012³â 11¿ù 10ÀÏ
Á¦ ¸ñ ½Å°æ¿Ü°úÇÐ
ÃâÆÇ»ç ´ëÇѽŰæ¿Ü°úÇÐȸ ¹ßÇàÀÏ 2012³â 10¿ù 18ÀÏ
Á¦ ¸ñ Atlas of Practical Neuroendoscopy
ÃâÆÇ»ç ¿¬¼¼´ëÇб³ ´ëÇÐÃâÆÇ¹®È­¿ø ¹ßÇàÀÏ 2001³â 04¿ù 12ÀÏ
¿¬±¸ ¾ÆÀÌÄÜ

ÁÖ¿ä³í¹®

ÃÑ 6°Ç
Á¦ ¸ñ Influence of Concurrent and Adjuvant Temozolomide on Health-Related Quality of Life of Patients with Grade III Gliomas
¹ßÇ¥³âµµ 2022 ¹ßÇ¥Áö Cancer Research and Treatment
Á¦ ¸ñ Concurrent and Adjuvant Temozolomide for Newly Diagnosed Grade III Gliomas without 1p/19q Co-deletion: A Randomized, Open-Label, Phase 2 Study (KNOG-1101 Study)
¹ßÇ¥³âµµ 2020 ¹ßÇ¥Áö Cancer Research and Treatment
Á¦ ¸ñ Dramatic unilateral decrease in uptake via the dopamine transporter: Imaging in a patient with hemiparkinsonism following the lacunar stroke in substantia nigra
¹ßÇ¥³âµµ 2019 ¹ßÇ¥Áö Neurology Asia
Á¦ ¸ñ Impact of adjuvant treatments on survival in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup study
¹ßÇ¥³âµµ 2018 ¹ßÇ¥Áö Journal of Neuro-oncology
Á¦ ¸ñ Multi-institutional study of treatment patterns in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup study
¹ßÇ¥³âµµ 2018 ¹ßÇ¥Áö Journal of Neuro-oncology
Á¦ ¸ñ Rapidly Growing Anaplastic Ganglioglioma Mimicking Brain Metastasis in a Middle-Aged Woman: A Case Report
¹ßÇ¥³âµµ 2018 ¹ßÇ¥Áö ´ëÇÑ¿µ»óÀÇÇÐȸÁö

¸íÀÇqna ¸íÀÇ ¼Ò¼Óº´¿ø

°¡Å縯°üµ¿´ëÇб³ ±¹Á¦¼º¸ðº´¿ø

Á¾ÇÕº´¿ø
ÀüÈ­ ¾ÆÀÌÄÜ ´ëÇ¥¹øÈ£
1600-8291
À¥»çÀÌÆ® ¾ÆÀÌÄÜȨÆäÀÌÁö

ÁÖ¿ä½Ã¼³

ÀÀ±Þ½Ç ÀÀ±Þ½Ç
Ŭ¸®´Ð Ŭ¸®´Ð
Á¾ÇÕ°ËÁø¼¾ÅÍ Á¾ÇÕ°ËÁø¼¾ÅÍ
¾Ï¼¾ÅÍ ¾Ï¼¾ÅÍ
ÁÖÂ÷½Ã¼³ ÁÖÂ÷½Ã¼³

°¡Å縯°üµ¿´ëÇб³ ±¹Á¦¼º¸ðº´¿øÀº °¡Å縯±³È¸ Á¤½ÅÀÎ ±×¸®½ºµµÀÇ ÀǼú·Î ÀηùÀÇ ¾ÆÇ ¸ö°ú ¸¶À½À» Ä¡À¯ÇÑ´Ù´Â ¹Ì¼Ç ¾Æ·¡ ¼³¸³µÆ´Ù. ÀÎõ±¹Á¦°øÇ×°ú °¡Àå °¡±î¿î ´ëÇѹα¹ÀÇ °ü¹® º´¿øÀÌÀÚ, ÀÎõ ¼­±¸¿Í ¿µÁ¾µµ, °­È­, ±èÆ÷ Áö¿ª ÃÖÃÊ-À¯ÀÏÀÇ ´ëÇк´¿øÀÌ´Ù. ½ÉÀåÇ÷°ü¼¾ÅÍ, ·Îº¿¼ö¼ú¼¾ÅÍ, °ÅÁ¡Áö¿ª ÀÀ±ÞÀÇ·á¼¾ÅÍ, ±¹Á¦Áø·á¼¾ÅÍ µî Àü¹® ¼¾Å͸¦ ¿î¿µÇϸç ÁßÁõÀÀ±ÞÁúȯ Ä¡·á¿¡ Èû¾²°í ÀÖ´Ù.

°¡Å縯°üµ¿´ëÇб³ ±¹Á¦¼º¸ðº´¿ø À̹ÌÁö

ÀÎõ±¤¿ª½Ã ¼­±¸ ½É°î·Î 100¹ø±æ 25

Ȩ
³»°¡ ¾Ë°íÀÖ´Â ¸íÀǸ¦ ÃßÃµÇØÁÖ¼¼¿ä